... A web-based Atlas of Patient-Derived Xenografts of cancer patients:A resource of MURAL PDX data
Home
Search by IDs Search by Gene
Browse
With gene expression Without gene expression Mutation & CNV Plot
Patient Tumor & Clinical details PDX & PDXBiomarker details
View & Update
Statistics



PDX model details

PDX ID 387.38A
Host Strain(and Source) NSG
Source: Monash University
Host Strain Immune system Humanized NO
Host Type Testosterone supplemented
Graft Site Subcutaneous
Current Generation
(* indicates number of generations grown in Castrate host)
 19
Average PDX Generation Time (days +/- SEM) 57 ± 3
Tumor preparation Tumor solid
Tumor Characterization Technology Histology, IHC, STR profiling, targeted DNA sequencing, RNAseq
Tumor confirmed not to be of Mouse/EBV origin Yes; negative for CD45 and/or positive for human CK8/18 and/or human mitochondria by IHC
Passage QA performed Routine QA every 2-3 passages
Associated meta data
PDX model availability Yes (fixed, frozen)
Governance restriction for distribution Available to investigators with appropriate ethics approvals, approved EOI from MURAL committee, and material transfer agreements
Pubmed ID 34413304
Markers 387.38A
AR Y
PSA Y
PSMA Y
NE Y
ERG Y
This heatmap displays the call type of curated CNVs in the presented samples.
This heatmap displays the call type of CNVs in commonly occurred samples.

PDX ID Gene Symbol CNV Log2 CNV Copy CNV Call Experiments name Platform Reference genome
387.38A AR 4.07951 16.9065 gain-high MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A KDM6A 1.58853 3.00743 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A KDM6A 1.218 2.32624 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A MYC 1.1712 4.50398 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A GNAS 0.824555 3.54198 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A ARID2 0.717132 3.28782 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A U2AF1 0.676095 3.19562 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A MLH1 0.636635 3.1094 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A CTNNB1 0.636635 3.1094 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A MRE11A 0.611798 3.05632 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A AKT1 0.496914 2.82238 gain MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A FANCA -0.759587 1.18133 loss MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A CDKN1B -0.79712 1.15099 loss MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19
387.38A TP53 -1.36492 0.776512 loss MURAL Prostate Cancer PDX collection Targeted GARVAN Panel hg19

Clinical Information

Sample Number 387.38A
Sample Site Para-tracheal lymph node
Sample source Autopsy
Pathology Tumor Diagnosis None
Gleason Score None
Primary Gleason Score None
Secondary Gleason Score None
Tertiary Gleason Score None
ISUP Grade Group
Tumor Grade
D'Amico Risk Classification
Tumor Volume (in cc) 0.0
Treatment Prior to Specimen Collection ADT, docetaxel, cabazitaxel, enzalutamide, lutetium PSMA, pembrolizumab

Patient Information

Patient Number 387
Sex Male
Diagnosis Prostate Cancer
PSA at diagnosis (ng/mL) NA
Consent to share data

Patient Tumor Collection (Current Model)
Tumour sample ID 387.38A
Patient Age (binned in 5 year age groups) 60-64
This heatmap displays the mutations of curated sequence variants.
Download The Mut plot is not shown
PDX ID Gene Symbol Depth ALT_FREQ Consequence Exon GnomAD_AF CADD_PHRED Clinvar_clnsig Platform Experiments Name Reference Library Type Instrument Type
387.38A TP53 491 0.97 missense_variant '6/11 . 24.8 Conflicting_interpretations_of_pathogenicity Targeted GARVAN Panel MURAL Prostate Cancer PDX collection hg19 paired Illumina HiSeq 2500
387.38A KMT2C 511 0.78 missense_variant '43/59 4.48E-05 23.2 - Targeted GARVAN Panel MURAL Prostate Cancer PDX collection hg19 paired Illumina HiSeq 2500
387.38A CRLF2 820 0.76 missense_variant '6/6 . 9.837 not_provided Targeted GARVAN Panel MURAL Prostate Cancer PDX collection hg19 paired Illumina HiSeq 2500
387.38A NOTCH3 114 0.47 missense_variant '25/33 2.22E-05 16.93 - Targeted GARVAN Panel MURAL Prostate Cancer PDX collection hg19 paired Illumina HiSeq 2500
387.38A DPCR1 628 0.34 stop_gained '2/3 . 24.6 - Targeted GARVAN Panel MURAL Prostate Cancer PDX collection hg19 paired Illumina HiSeq 2500
387.38A DPCR1 628 0.34 stop_gained '2/3 . 24.6 - Targeted GARVAN Panel MURAL Prostate Cancer PDX collection hg19 paired Illumina HiSeq 2500